Clinical Trial Detail

NCT ID NCT02452008
Title Study of TGF-Beta Receptor Inhibitor LY2157299 and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

prostate cancer

Therapies

Galunisertib

Enzalutamide

Age Groups: adult

No variant requirements are available.